L L Trademark

Trademark Overview


On Thursday, March 7, 2024, a trademark application was filed for L L with the United States Patent and Trademark Office. The USPTO has given the L L trademark a serial number of 98439337. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, April 1, 2025. This trademark is owned by CIATRIX, Inc.. The L L trademark is filed in the Medical Instrument Products category with the following description:

medical devices for use in treating neurodegenerative diseases, neurocognitive diseases, Alzheimer’s disease, symptom of stroke, symptom of traumatic brain injury, cerebrospinal fluid dynamics dysfunction, neuroinflammation, and increased intracranial fluid; therapeutic devices using cerebrospinal fluid motion, cerebrospinal fluid pressure changes, spinal motion, and respiratory inhalation and exhalation to improve performance of lymphatic system, performance of glymphatic system, posture, glymphatic clearance, drug delivery in cerebrospinal fluid, and drug delivery in blood and to lower brain wave activity to provide relief from neurodegenerative diseases, neurocognitive diseases, Alzheimer’s disease, symptom of stroke, symptom of traumatic brain injury, cerebrospinal fluid dynamics dysfunction, neuroinflammation, and increased intracranial fluid; diagnostic devices, namely, medical diagnostic apparatus for testing cerebrospinal fluid dynamics
l l

General Information


Serial Number98439337
Word MarkL L
Filing DateThursday, March 7, 2024
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, April 1, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 4, 2025

Trademark Statements


Description of MarkThe mark consists of an L-shape in left lower corner with an opposing backwards and inverted L-shape in the top right corner forming a broken square-like design surrounded by an oval-like border.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and Servicesmedical devices for use in treating neurodegenerative diseases, neurocognitive diseases, Alzheimer’s disease, symptom of stroke, symptom of traumatic brain injury, cerebrospinal fluid dynamics dysfunction, neuroinflammation, and increased intracranial fluid; therapeutic devices using cerebrospinal fluid motion, cerebrospinal fluid pressure changes, spinal motion, and respiratory inhalation and exhalation to improve performance of lymphatic system, performance of glymphatic system, posture, glymphatic clearance, drug delivery in cerebrospinal fluid, and drug delivery in blood and to lower brain wave activity to provide relief from neurodegenerative diseases, neurocognitive diseases, Alzheimer’s disease, symptom of stroke, symptom of traumatic brain injury, cerebrospinal fluid dynamics dysfunction, neuroinflammation, and increased intracranial fluid; diagnostic devices, namely, medical diagnostic apparatus for testing cerebrospinal fluid dynamics

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, March 7, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCIATRIX, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLEWES, DE 19958

Party NameCIATRIX, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLEWES, DE 19958

Trademark Events


Event DateEvent Description
Monday, July 22, 2024NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, March 7, 2024NEW APPLICATION ENTERED
Monday, July 22, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 20, 2024ASSIGNED TO EXAMINER
Tuesday, October 1, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 2, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 2, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 2, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 13, 2025EXAMINERS AMENDMENT -WRITTEN
Monday, January 13, 2025EXAMINER'S AMENDMENT ENTERED
Monday, January 13, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 13, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, January 13, 2025EXAMINERS AMENDMENT E-MAILED
Wednesday, January 29, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 4, 2025PUBLISHED FOR OPPOSITION
Tuesday, February 4, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 1, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 1, 2024NON-FINAL ACTION E-MAILED
Tuesday, October 1, 2024NON-FINAL ACTION WRITTEN